Announcements Trials

Browse Landscape

Status

Recruiting 38 Completed 34 Terminated 13 Unknown 11 Active not recruiting 7 Withdrawn 3 Enrolling by invitation 2 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Vulvar Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

E 7107 2 Carboplatin 2 palbociclib 1 gedatolisib 1 eniluracil 1 dabrafenib 1 abarelix 1 Topotecan 1 Standard of Care 1 Radionuclide Imaging 1 Radiofrequency Ablation 1 Practice Guidelines as Topic 1 Positron-Emission Tomography 1 Passive Cutaneous Anaphylaxis 1 Paclitaxel 1 NUC-1031 1 Morphine 1 Methadone 1 Maltose 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 KB004 1 Injections 1 Infusions, Parenteral 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hydromorphone 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 Flucytosine 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Neoplasms × Blood Specimen Collection × Clear all

NCT07046936 2026-05-26

MITO-RES

Wake Forest University Health Sciences

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡